Clinical Trials Logo

Joint Diseases clinical trials

View clinical trials related to Joint Diseases.

Filter by:

NCT ID: NCT02397070 Recruiting - Clinical trials for Musculoskeletal Diseases

Effectiveness of a Jaw Exercise Program in Temporomandibular Disorders Patients

Start date: January 2015
Phase: N/A
Study type: Interventional

This study evaluates the effect of jaw exercise therapy in the treatment of temporomandibular disorder patients (TMD). An eligible group of patients will be treated with that therapy (experimental group) and another group will be treated with counseling and occlusal splint (control group), considered the standard therapy for TMD.

NCT ID: NCT02390336 Completed - Clinical trials for Musculoskeletal Diseases

Mobilization With Movement in Patients With Osteoarthritis of the Hip

MWM
Start date: March 2015
Phase: N/A
Study type: Interventional

The concept of mobilization with movement, also referred to as a Mulligan mobilization, has not been studied in patients with hip osteoarthritis, subsisting questions about the possible effects in this population. The aim of this randomized controlled study is to compare the immediate effects of Mulligan mobilization with movement technique of pain, range of motion and physical function in patients with osteoarthritis of the hip.

NCT ID: NCT02386579 Completed - Diabetes Mellitus Clinical Trials

Characterization of Local and Systemic Bone Markers in Diabetes Patients With Charcot Osteoarthropathy

Start date: February 2015
Phase:
Study type: Observational

The study is designed to investigate biomarkers related to bone turnover in diabetics with charcot foot. This is done by measuring local blood samples in the feet, and systemically in a vene and an artery. Measurements are done before and after cooling the feet in icewater to lower the bloodflow. Patients will be compared with healthy diabetic controls.

NCT ID: NCT02382289 Completed - Clinical trials for Radiofrequency Ablation

Radiofrequency in Sacroiliac Arthropathy;Bipolar RF 6 Points Versus Monopolar RF at 6 and 3 Points

RFSIBIMONO6
Start date: September 2014
Phase: N/A
Study type: Interventional

Expecting using bipolar RF at six points, in spite of potentially consuming more intraoperative time, to be more effective and long lasting in the management of pain resultant from chronic sacroiliac joint arthropathy than the other 2 techniques using the monopolar RF even if using six points.

NCT ID: NCT02380092 Active, not recruiting - Clinical trials for Degenerative Joint Disease

Post Market Clinical Follow Up of LEGION™ Primary TKS With VERILAST™

Start date: September 2015
Phase:
Study type: Observational

LEGION™ Primary Total Knee System is CE-marked and marketed in all study regions. This study serves as post-market surveillance for LEGION™ Primary Total Knee System with the VERILAST™ bearing surface (OXINIUM™ femoral component with highly cross-linked polyethylene tibial insert). All study subjects will receive a LEGION™ Primary Total Knee System with VERILAST™ bearing surface and the results will be analysed against historical data from patients who received a Genesis II knee replacement.

NCT ID: NCT02373644 Completed - Clinical trials for Sacroiliac Joint Dysfunction

Spinal Manipulation and Dry Needling Versus Conventional Physical Therapy in Patients With Sacroiliac Dysfunction

Start date: February 21, 2015
Phase: N/A
Study type: Interventional

The purpose of the research project is to compare the effectiveness of non-thrust mobilization and exercise versus thrust manipulation and dry needling in patients with sacroiliac dysfunction. Physical therapists commonly use both approaches to treat sacroiliac joint dysfunction, and this study is attempting to determine if one approach is more effective than the other.

NCT ID: NCT02351414 Active, not recruiting - Joint Disease Clinical Trials

Post Market Follow-Up Study of the EVOLUTION® Total Knee Arthroplasty System With Cruciate Sacrificing Inserts

AMETHYST
Start date: June 15, 2015
Phase:
Study type: Observational

MPO is conducting this PMCF study to evaluate the safety and efficacy of its EVOLUTION® Total Knee Arthroplasty (TKA) components marketed in the EU. These types of studies are required by regulatory authorities for all devices that do not have medium to long-term clinical evidence available at the time of gaining approval to market in the EU. This study has been designed in accordance with MEDDEV 2.12/2 rev 2.

NCT ID: NCT02346110 Completed - Clinical trials for Arthrosis, Unspecified, Ankle and Foot

Protracted Effect of the Ultrasound-guided Saphenous Block

PEUSB
Start date: April 2015
Phase: Phase 4
Study type: Interventional

This study focuses on optimizing the postoperative pain treatment after major foot and ankle surgery by prolonging the duration of the ultrasound-guided saphenous block. The currently used single shot saphenous block only covers half of the pain intensive period from the saphenous territory, which results in a sharp, break-through pain requiring opioids. The hypothesis is that this protracted mixture will keep the patients free of pain without the use of opioids for the entire pain intensive period and thus increase rehabilitation and patients' satisfaction.

NCT ID: NCT02341079 Withdrawn - Osteoarthritis Clinical Trials

Intraoperative Liposomal Bupivacaine Injection in Primary Total Knee Arthroplasty

Start date: March 2015
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of the study is to evaluate the efficacy of local infiltration of liposomal bupivacaine versus use of an indwelling femoral peripheral nerve block in controlling early postoperative pain in primary total knee arthroplasty. The investigators hope to demonstrate equivalency of treatment modalities to provide an alternative to the commonly used treatment of femoral nerve blockade.

NCT ID: NCT02339610 Completed - Clinical trials for Non-inflammatory Degenerative Joint Disease

Evaluation of Post-Operative Recovery in ATTUNE® Total Knee Arthroplasty

Start date: January 1, 2015
Phase:
Study type: Observational

This post-marketing investigation will evaluate the rate of recovery of the ATTUNE knee from the time of surgery through the 6 month endpoint in patients with severely painful and/or severely disabling Non-inflammatory Degenerative Joint Disease (NIDJD).